It is now well-known that neoplasms that are strongly positive for PD-L1 show a high rate of response to PD-1/PD-L1 blockade, which may therefore represent a potentially effective treatment in this type of lymphoma [51,52,53,54,55]. The gene discussed is CD274; the disease is lymphoma.